Cargando…
Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis
BACKGROUND: Ovarian cancer (OC) is the deadliest cause in the gynecological malignancies. Most OC patients are diagnosed in advanced stages with less than 40% of women cured. However, the possible mechanism underlying tumorigenesis and candidate biomarkers remain to be further elucidated. RESULTS: G...
Autores principales: | Shen, Jiayu, Yu, Shuqian, Sun, Xiwen, Yin, Meichen, Fei, Jing, Zhou, Jianwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857166/ https://www.ncbi.nlm.nih.gov/pubmed/31729978 http://dx.doi.org/10.1186/s13048-019-0578-1 |
Ejemplares similares
-
KNDC1 Is a Predictive Marker of Malignant Transformation in Borderline Ovarian Tumors
por: Yu, Shuqian, et al.
Publicado: (2020) -
Tumor-Associated Macrophages (TAMs): A Critical Activator In Ovarian Cancer Metastasis
por: Yin, Meichen, et al.
Publicado: (2019) -
Screening and identification of key biomarkers in bladder carcinoma: Evidence from bioinformatics analysis
por: Yan, Meiqin, et al.
Publicado: (2018) -
Insights Into the Role of Mesothelin as a Diagnostic and Therapeutic Target in Ovarian Carcinoma
por: Shen, Jiayu, et al.
Publicado: (2020) -
Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis
por: Li, Lin, et al.
Publicado: (2017)